<SEC-DOCUMENT>0000899243-22-012518-index.html : 20220328
<SEC-HEADER>0000899243-22-012518.hdr.sgml : 20220328
<ACCEPTANCE-DATETIME>20220328185958
ACCESSION NUMBER:		0000899243-22-012518
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20211111
FILED AS OF DATE:		20220328
DATE AS OF CHANGE:		20220328

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			LaFrance Norman D.
		CENTRAL INDEX KEY:			0001397768

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34375
		FILM NUMBER:		22776899

	MAIL ADDRESS:	
		STREET 1:		MOLECULAR INSIGHT PHARMCEUTICALS, INC.
		STREET 2:		160 SECOND STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PLUS THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001095981
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				330827593
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		4200 MARATHON BLVD.
		STREET 2:		SUITE 200
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78756
		BUSINESS PHONE:		737.255.7194

	MAIL ADDRESS:	
		STREET 1:		4200 MARATHON BLVD.
		STREET 2:		SUITE 200
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78756

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CYTORI THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20050712

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MACROPORE INC
		DATE OF NAME CHANGE:	20010320
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>doc4a.xml
<DESCRIPTION>FORM 4/A SUBMISSION
<TEXT>
Document 1 - file: doc4a.html

Document 1 - RAW XML: doc4a.xml

</DOCUMENT>
</SEC-DOCUMENT>